Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Net Cash Flow (2016 - 2025)

Amphastar Pharmaceuticals has reported Net Cash Flow over the past 13 years, most recently at -$46.1 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$46.1 million for Q4 2025, down 13.79% from a year ago — trailing twelve months through Dec 2025 was $18.4 million (up 144.68% YoY), and the annual figure for FY2025 was $18.4 million, up 144.68%.
  • Net Cash Flow for Q4 2025 was -$46.1 million at Amphastar Pharmaceuticals, down from $28.6 million in the prior quarter.
  • Over the last five years, Net Cash Flow for AMPH hit a ceiling of $119.8 million in Q3 2023 and a floor of -$126.3 million in Q4 2023.
  • Median Net Cash Flow over the past 5 years was $3.7 million (2024), compared with a mean of $3.8 million.
  • Peak annual rise in Net Cash Flow hit 1459.14% in 2023, while the deepest fall reached 10738.45% in 2023.
  • Amphastar Pharmaceuticals' Net Cash Flow stood at $19.8 million in 2021, then plummeted by 105.89% to -$1.2 million in 2022, then crashed by 10738.45% to -$126.3 million in 2023, then surged by 67.93% to -$40.5 million in 2024, then fell by 13.79% to -$46.1 million in 2025.
  • The last three reported values for Net Cash Flow were -$46.1 million (Q4 2025), $28.6 million (Q3 2025), and $4.8 million (Q2 2025) per Business Quant data.